Alexandr V. Zagrebelnyi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandr V. Zagrebelnyi has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Sergey Yu. Martsevich
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
46 shared publications - Oksana Mikhailovna Drapkina
National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia
38 shared publications - Natalia P. Kutishenko
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
35 shared publications - Yuliya V. Lukina
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
27 shared publications - N. A. Dmitrieva
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
23 shared publications - O. V. Lerman
National Medical Research Center for Therapy and Preventive Medicine
22 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Publishing House ABV Press in The Clinician
- Vol. 20 (2) , 38-52
Potentially adverse drug-drug interactions in patients with cardiovascular diseases and non-cardiovascular multimorbidity: data from the CHIP registry
Aim. To evaluate the frequency and types of potential drug-drug interactions (pDDIs) in outpatients with cardiovascular diseases (CVD) and multimorbidity within an ambulatory registry. Material and methods. This observational cross-sectional study was conducted as part of the CHIP (Chuvashia Inappropriate Prescribing) registry, focusing on multimorbid patients over 50 years of age attending a cardiology clinic. Medical history included all medications taken within the two months prior to the study, including therapy for comorbidities. pDDIs were identified primarily using Medscape and Lexicomp® drug interaction checkers, supplemented by screening tools (PROMPT (Prescribing Optimisation Method for Prescribing in Older People), Beers, and STOPP / START criteria Screening Tool of Older Persons’ Prescriptions / Screening Tool to Alert to Right Treatment)) and evidence-based medicine data. Results. The CHIP registry included 300 patients: 120 (40 %) men and 180 (60 %) women (mean age 66.4 ± 7.6 years). pDDIs were identified in 231 patients (77 %). Antihypertensive and antithrombotic agents were the primary drug classes associated with pDDIs, likely due to their frequent inclusion in comorbid cardiovascular therapy. Within the structure of inappropriate prescriptions (n = 662), expert assessment identified 393 pDDIs. Subsequent verification using Lexicomp® and Medscape expanded the number of identified pDDIs to 987. Interactions requiring clinical monitoring predominated (58 % and 58.1 %, respectively). Therapy modification or discontinuation were required in 10.8 % (Lexicomp®) and 11.9 % (Medscape) of pDDIs. Lexicomp® recorded interactions of minimal clinical significance 10 times more frequently than Medscape (13.5 % versus 1.3 %). Additionally, in 11.1 % of cases, assessment via Medscape was not possible due to the absence of specific drugs in its database. Critical drug combinations were registered in 17 cases: 10 (1 %) resulted from physician prescriptions and 7 (0.7 %) from patient self-medication. Conclusion. In the CHIP registry, 77 % of CVD patients had pDDIs, most of which occurred with cardiovascular medications. Identified potentially dangerous combinations resulted from physician prescriptions in 10 cases and self-medication in 7 cases. Automated interaction checkers Lexicomp® and Medscape significantly increase the number of identified pDDIs compared to expert assessment. Lexicomp® features a broader drug database and higher sensitivity for detecting minor pDDIs, while Medscape demonstrates high selectivity for clinically significant interactions.
- 6 November 2026
- Published by Publishing House ABV Press in The Clinician
- Vol. 20 (2) , 38-52
Open AccessPotentially adverse drug-drug interactions in patients with cardiovascular diseases and non-cardiovascular multimorbidity: data from the CHIP registry
Aim. To evaluate the frequency and types of potential drug-drug interactions (pDDIs) in outpatients with cardiovascular diseases (CVD) and multimorbidity within an ambulatory registry. Material and methods. This observational cross-sectional study was conducted as part of the CHIP (Chuvashia Inappropriate Prescribing) registry, focusing on multimorbid patients over 50 years of age attending a cardiology clinic. Medical history included all medications taken within the two months prior to the study, including therapy for comorbidities. pDDIs were identified primarily using Medscape and Lexicomp® drug interaction checkers, supplemented by screening tools (PROMPT (Prescribing Optimisation Method for Prescribing in Older People), Beers, and STOPP / START criteria Screening Tool of Older Persons’ Prescriptions / Screening Tool to Alert to Right Treatment)) and evidence-based medicine data. Results. The CHIP registry included 300 patients: 120 (40 %) men and 180 (60 %) women (mean age 66.4 ± 7.6 years). pDDIs were identified in 231 patients (77 %). Antihypertensive and antithrombotic agents were the primary drug classes associated with pDDIs, likely due to their frequent inclusion in comorbid cardiovascular therapy. Within the structure of inappropriate prescriptions (n = 662), expert assessment identified 393 pDDIs. Subsequent verification using Lexicomp® and Medscape expanded the number of identified pDDIs to 987. Interactions requiring clinical monitoring predominated (58 % and 58.1 %, respectively). Therapy modification or discontinuation were required in 10.8 % (Lexicomp®) and 11.9 % (Medscape) of pDDIs. Lexicomp® recorded interactions of minimal clinical significance 10 times more frequently than Medscape (13.5 % versus 1.3 %). Additionally, in 11.1 % of cases, assessment via Medscape was not possible due to the absence of specific drugs in its database. Critical drug combinations were registered in 17 cases: 10 (1 %) resulted from physician prescriptions and 7 (0.7 %) from patient self-medication. Conclusion. In the CHIP registry, 77 % of CVD patients had pDDIs, most of which occurred with cardiovascular medications. Identified potentially dangerous combinations resulted from physician prescriptions in 10 cases and self-medication in 7 cases. Automated interaction checkers Lexicomp® and Medscape significantly increase the number of identified pDDIs compared to expert assessment. Lexicomp® features a broader drug database and higher sensitivity for detecting minor pDDIs, while Medscape demonstrates high selectivity for clinically significant interactions.
- Open Access
- 31 July 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (6) , 4858
Changes in the prognostic value of diabetes in patients after cerebrovascular accident during long-term follow-up: data from the REGION-M registry
Aim . To evaluate the prognostic value of type 2 diabetes (T2D) and to study the relationship between T2D and the risk of mortality at different stages of long-term outpatient follow-up in patients with cerebrovascular accidents (CVA). Material and methods . Within the registry of patients who suffered a stroke in 2012-2017, medical records and discharge summaries after the reference stroke (n=900), as well as outpatient records of patients (n=684), were analyzed. During the outpatient phase of follow-up completed in 2025 within the prospective part of the REGION-M registry, the long-term prognosis of patients after stroke was assessed and the role of type 2 diabetes as a possible prognostic factor was determined at various follow-up stages (2017-2025). The primary endpoint was all-cause death. Results . The entire outpatient phase of observation was divided into four following stages: Stage 1 (median (Me) 22 [13; 38] months) — from the reference stroke to hospital discharge (2017); Stage 2 (Me 57 [45; 71] months) — outpatient follow-up (2017-2020); Stage 3 (Me 79 [68; 95] months) — outpatient follow-up (2020-2022); Stage 4 (Me 114 [103; 128] months) — outpatient follow-up (2022-2025). The median total follow-up time was 9,5 years, during this period. In general, no significant differences in survival were found in patients depending on T2D: hazard ratio (HR) =1,24; 95% confidence interval (CI): 0,985-1,567 (p=0,067), however, Piecewise Cox Regression confirmed a significant association between T2D and the death risk in patients with a history of stroke at stages 1 and 3 of outpatient follow-up as follows: direct association at stage 1 and inverse association at stage 3 (HR=0,67, 95% CI: 0,45-0,99, p=0,044 and HR=1,70 95% CI: 1,07-2,71, p=0,026). Conclusion . In the prospective REGION-M registry part, the long-term prognosis of patients with a history of stroke was assessed at various time points. T2D has an independent negative prognostic value at certain stages of long-term follow-up of such patients.
- 31 July 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (6) , 4858
Open AccessChanges in the prognostic value of diabetes in patients after cerebrovascular accident during long-term follow-up: data from the REGION-M registry
Aim . To evaluate the prognostic value of type 2 diabetes (T2D) and to study the relationship between T2D and the risk of mortality at different stages of long-term outpatient follow-up in patients with cerebrovascular accidents (CVA). Material and methods . Within the registry of patients who suffered a stroke in 2012-2017, medical records and discharge summaries after the reference stroke (n=900), as well as outpatient records of patients (n=684), were analyzed. During the outpatient phase of follow-up completed in 2025 within the prospective part of the REGION-M registry, the long-term prognosis of patients after stroke was assessed and the role of type 2 diabetes as a possible prognostic factor was determined at various follow-up stages (2017-2025). The primary endpoint was all-cause death. Results . The entire outpatient phase of observation was divided into four following stages: Stage 1 (median (Me) 22 [13; 38] months) — from the reference stroke to hospital discharge (2017); Stage 2 (Me 57 [45; 71] months) — outpatient follow-up (2017-2020); Stage 3 (Me 79 [68; 95] months) — outpatient follow-up (2020-2022); Stage 4 (Me 114 [103; 128] months) — outpatient follow-up (2022-2025). The median total follow-up time was 9,5 years, during this period. In general, no significant differences in survival were found in patients depending on T2D: hazard ratio (HR) =1,24; 95% confidence interval (CI): 0,985-1,567 (p=0,067), however, Piecewise Cox Regression confirmed a significant association between T2D and the death risk in patients with a history of stroke at stages 1 and 3 of outpatient follow-up as follows: direct association at stage 1 and inverse association at stage 3 (HR=0,67, 95% CI: 0,45-0,99, p=0,044 and HR=1,70 95% CI: 1,07-2,71, p=0,026). Conclusion . In the prospective REGION-M registry part, the long-term prognosis of patients with a history of stroke was assessed at various time points. T2D has an independent negative prognostic value at certain stages of long-term follow-up of such patients.
- Open Access
- 31 July 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (6) , 4828
Five-year outcomes in patients with non-ST-segment elevation acute coronary syndrome in the prospective CONTRAST registry
Aim . To study 5-year outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in a prospective registry. Material and methods . The Registry of Acute Coronary Syndrome without ST-segment Elevation in the Regional Vascular Center (CONTRAST) included 136 patients admitted to the Sergiyev Posad Vascular Center from October 2018 to March 2019 with a diagnosis of NSTE-ACS. At discharge, the patients were diagnosed with unstable angina (UA) (n=112) or non-ST-segment elevation MI (NSTEMI) (n=24). Five-year outcomes were analyzed. Results . The primary composite endpoint (CEP), including all-cause death, nonfatal myocardial infarction (MI), cerebrovascular accident, and emergency hospitalizations for cardiovascular causes, was recorded in 60 patients. Patients with CEP did not differ in age, sex, or risk factors compared to patients without CEP, but they were more likely to have a history of MI, hypokinesis on echocardiography, and a mildly reduced left ventricular ejection fraction. There were no significant differences in the incidence of CEP between patients with NSTEMI and UA. Multivariate Cox regression analysis showed that independent CEP predictors included hypokinesia area on echocardiography, a moderately reduced left ventricular ejection fraction, pleural effusion in the acute phase, and atrial fibrillation. Patients with NSTEMI and UA did not differ in the likelihood of CEP. PCI during and after the reference hospitalization also did not affect the likelihood of CEP. Conclusion . In a 5-year prospective follow-up study of patients with NSTE-ACS, the likelihood of adverse outcomes was determined primarily by clinical and imaging risk factors identified in the acute phase and was independent of the formal discharge diagnosis (UA or NSTEMI).
- 31 July 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (6) , 4828
Open AccessFive-year outcomes in patients with non-ST-segment elevation acute coronary syndrome in the prospective CONTRAST registry
Aim . To study 5-year outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in a prospective registry. Material and methods . The Registry of Acute Coronary Syndrome without ST-segment Elevation in the Regional Vascular Center (CONTRAST) included 136 patients admitted to the Sergiyev Posad Vascular Center from October 2018 to March 2019 with a diagnosis of NSTE-ACS. At discharge, the patients were diagnosed with unstable angina (UA) (n=112) or non-ST-segment elevation MI (NSTEMI) (n=24). Five-year outcomes were analyzed. Results . The primary composite endpoint (CEP), including all-cause death, nonfatal myocardial infarction (MI), cerebrovascular accident, and emergency hospitalizations for cardiovascular causes, was recorded in 60 patients. Patients with CEP did not differ in age, sex, or risk factors compared to patients without CEP, but they were more likely to have a history of MI, hypokinesis on echocardiography, and a mildly reduced left ventricular ejection fraction. There were no significant differences in the incidence of CEP between patients with NSTEMI and UA. Multivariate Cox regression analysis showed that independent CEP predictors included hypokinesia area on echocardiography, a moderately reduced left ventricular ejection fraction, pleural effusion in the acute phase, and atrial fibrillation. Patients with NSTEMI and UA did not differ in the likelihood of CEP. PCI during and after the reference hospitalization also did not affect the likelihood of CEP. Conclusion . In a 5-year prospective follow-up study of patients with NSTE-ACS, the likelihood of adverse outcomes was determined primarily by clinical and imaging risk factors identified in the acute phase and was independent of the formal discharge diagnosis (UA or NSTEMI).
- 11 April 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (1) , 45-51
Inappropriate prescribing in patients with cardiovascular diseases and non-cardiac multimorbidity (outpatient registry data)
Aim . To assess the prevalence of inappropriate prescribing (IP) in patients with cardiovascular diseases and concomitant non-cardiac multimorbidity using data from an outpatient registry. Material and methods. The study sequentially included patients aged over 50 years with cardiovascular diseases and at least one concomitant non-cardiac condition requiring drug therapy. Patients completed original questionnaires regarding their medication therapy. Prescriptions were evaluated for inappropriateness based on their compliance with the official Summary of Product Characteristics (SmPC), clinical practice guidelines, and contemporary criteria for inappropriate prescribing. Results . The study included 300 patients (120 men and 180 women). Patients had 2 to 11 comorbidities, with a median (Me) of 5 [4;6]. A total of 2961 medications were prescribed; 2071 prescriptions (69.9%) were classified as IP. At least one IP was identified in 99% of patients, Me 6 [4;9] per patient. The most common categories of IP were: misprescribing — 32% (of which more than half were combinations with potentially harmful drug-drug interactions), underprescribing — 20.1%, and overprescribing — 14%. Two additional types of IP were identified: “careless prescribing” (prescriptions lacking essential information such as dosage, frequency, or administration instructions), accounting for 18.5% of IPs, and “delegated prescribing” (cases where the physician transferred the responsibility for therapeutic decisions to the patient), accounting for 13.9% of IPs. The proportion of IP increased significantly with the total number of prescribed drugs. Of the 103 identified inappropriate drug combinations, 61% were prescribed by a single physician, while 38.4% resulted from uncoordinated prescribing by multiple physicians. Conclusion . The prevalence of IP in patients with cardiovascular diseases and non-cardiac multimorbidity was substantial, at 70% of all prescriptions, consistent with rates in comparable international studies. Misprescribing was the predominant type of IP, with potentially harmful drug-drug interactions being the most common issue, accounting for 19.0% of all inappropriate prescriptions.
- 11 April 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (1) , 45-51
Inappropriate prescribing in patients with cardiovascular diseases and non-cardiac multimorbidity (outpatient registry data)
Aim . To assess the prevalence of inappropriate prescribing (IP) in patients with cardiovascular diseases and concomitant non-cardiac multimorbidity using data from an outpatient registry. Material and methods. The study sequentially included patients aged over 50 years with cardiovascular diseases and at least one concomitant non-cardiac condition requiring drug therapy. Patients completed original questionnaires regarding their medication therapy. Prescriptions were evaluated for inappropriateness based on their compliance with the official Summary of Product Characteristics (SmPC), clinical practice guidelines, and contemporary criteria for inappropriate prescribing. Results . The study included 300 patients (120 men and 180 women). Patients had 2 to 11 comorbidities, with a median (Me) of 5 [4;6]. A total of 2961 medications were prescribed; 2071 prescriptions (69.9%) were classified as IP. At least one IP was identified in 99% of patients, Me 6 [4;9] per patient. The most common categories of IP were: misprescribing — 32% (of which more than half were combinations with potentially harmful drug-drug interactions), underprescribing — 20.1%, and overprescribing — 14%. Two additional types of IP were identified: “careless prescribing” (prescriptions lacking essential information such as dosage, frequency, or administration instructions), accounting for 18.5% of IPs, and “delegated prescribing” (cases where the physician transferred the responsibility for therapeutic decisions to the patient), accounting for 13.9% of IPs. The proportion of IP increased significantly with the total number of prescribed drugs. Of the 103 identified inappropriate drug combinations, 61% were prescribed by a single physician, while 38.4% resulted from uncoordinated prescribing by multiple physicians. Conclusion . The prevalence of IP in patients with cardiovascular diseases and non-cardiac multimorbidity was substantial, at 70% of all prescriptions, consistent with rates in comparable international studies. Misprescribing was the predominant type of IP, with potentially harmful drug-drug interactions being the most common issue, accounting for 19.0% of all inappropriate prescriptions.
- 16 March 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32 (25) , 1-10
Self-Medication as a Type of Nonadherence in Cardiac Patients Over 50 Years of Age
Background: Self-medication is widely discussed regarding over-the-counter pharmaceutical drugs, as well as some prescription drugs, especially antibiotics. There are virtually no studies on selfmedication with cardiovascular drugs. Objective: To assess the prevalence of self-medication and adherence to prescribed treatment in patients with Cardiovascular Diseases (CVD) seeking advice at a cardiology dispensary. Methods: Our cross-sectional study included all patients aged 50 years or older (n=300) who repeatedly visited an outpatient clinic for CVD from December 14, 2023, to August 07, 2024. The information on previously prescribed and actually taken medicinal drugs by the patient was recorded during the visit. Patient-reported adherence was evaluated using a specific scale. Results: Self-medication was detected in 120 patients (40%) who either replaced or added drugs to the therapy prescribed by their attending physician. The most common recorded practice was self-prescription of medicinal drugs (106 cases, 88.3%), especially prescription drugs (72 of 106 patients, 67.9%). In 17 patients, self-medication led to inappropriate administration of the drug. In 7 patients (41.2%), self-medication resulted in potentially dangerous combinations of drugs. In 4 patients (23.5%), self-medication resulted in inadequate replacement of the drug, and in 6 patients (35.3%), duplication of drugs was noted. The majority of patients (76.3%) exhibited various violations of compliance with medical recommendations. Among patients practicing self-medication, there were more partially nonadherent patients, and in the subgroup without selfmedication, there were more completely nonadherent patients (p=0.008). Discussion: Self-medication is potentially associated with several risks, including delayed professional consultation, incorrect self-diagnosis, severe adverse reactions, dangerous drug-drug interactions, masking of severe conditions, and the risk of drug abuse. Existing literature predominantly focuses on self-medication with over-the-counter drugs. This study demonstrates that in the Russian Federation, self-medication (including the use of cardiovascular drugs) is remarkably prevalent. More than a third of the surveyed patients independently added new medications to their physician’s regimen or substituted prescribed ones. Moreover, more than half of the self-medications were for prescription drugs. Conclusion: Self-medication, as one of the options for nonadherence, was employed by 40% of CVD patients. In some cases, this has led to the emergence of potentially dangerous drug combinations.
- 16 March 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32 (25) , 1-10
Self-Medication as a Type of Nonadherence in Cardiac Patients Over 50 Years of Age
Background: Self-medication is widely discussed regarding over-the-counter pharmaceutical drugs, as well as some prescription drugs, especially antibiotics. There are virtually no studies on selfmedication with cardiovascular drugs. Objective: To assess the prevalence of self-medication and adherence to prescribed treatment in patients with Cardiovascular Diseases (CVD) seeking advice at a cardiology dispensary. Methods: Our cross-sectional study included all patients aged 50 years or older (n=300) who repeatedly visited an outpatient clinic for CVD from December 14, 2023, to August 07, 2024. The information on previously prescribed and actually taken medicinal drugs by the patient was recorded during the visit. Patient-reported adherence was evaluated using a specific scale. Results: Self-medication was detected in 120 patients (40%) who either replaced or added drugs to the therapy prescribed by their attending physician. The most common recorded practice was self-prescription of medicinal drugs (106 cases, 88.3%), especially prescription drugs (72 of 106 patients, 67.9%). In 17 patients, self-medication led to inappropriate administration of the drug. In 7 patients (41.2%), self-medication resulted in potentially dangerous combinations of drugs. In 4 patients (23.5%), self-medication resulted in inadequate replacement of the drug, and in 6 patients (35.3%), duplication of drugs was noted. The majority of patients (76.3%) exhibited various violations of compliance with medical recommendations. Among patients practicing self-medication, there were more partially nonadherent patients, and in the subgroup without selfmedication, there were more completely nonadherent patients (p=0.008). Discussion: Self-medication is potentially associated with several risks, including delayed professional consultation, incorrect self-diagnosis, severe adverse reactions, dangerous drug-drug interactions, masking of severe conditions, and the risk of drug abuse. Existing literature predominantly focuses on self-medication with over-the-counter drugs. This study demonstrates that in the Russian Federation, self-medication (including the use of cardiovascular drugs) is remarkably prevalent. More than a third of the surveyed patients independently added new medications to their physician’s regimen or substituted prescribed ones. Moreover, more than half of the self-medications were for prescription drugs. Conclusion: Self-medication, as one of the options for nonadherence, was employed by 40% of CVD patients. In some cases, this has led to the emergence of potentially dangerous drug combinations.
- Open Access
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4632
The STOKS acute coronary syndrome registry with online information monitoring: the problem of missing data
Aim. To analyze the frequency of missing data on the time of pain onset, obtained from medical records and patient questionnaires for acute coronary syndrome (ACS), and to evaluate the factors associated with this missing data. Material and methods. The study was conducted as part of the prospective Stupino Registry of ACS (STOCS), which has included all consecutive patients with ACS or suspected ACS admitted to the regional vascular center since January 10, 2025. Data on the time of angina pain onset were obtained from information in medical records and patient questionnaires. Results. Data from 261 patients included in the registry for the first 6 months of 2025 were analyzed. Referral diagnoses and diagnoses established upon hospital admission did not comply with current clinical guidelines in almost a third of patients. An analysis of patient records revealed that data on the angina onset was available for only 212 patients and missing for 49 (18,8%). Analysis of questionnaires completed by patients revealed missing information on pain onset in 3,1% of cases. The following factors were associated with missing data in patient records: older age, ST-segment elevation, and prior cerebrovascular accident. Older age and inhospital death were also associated with missing information in patient records. Conclusion. The study results showed that missing data on the pain onset was present in almost one in five patient records and in only 3% of structured questionnaires completed by patients. The lack of information about the pain onset in medical records and patient questionnaires is not accidental and is associated with a number of factors (advanced age, prior cerebrovascular accident, and inhospital death). Missing data on pain onset can be partially filled in through a structured patient survey, but it is virtually impossible to completely eliminate these omissions.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4632
Open AccessThe STOKS acute coronary syndrome registry with online information monitoring: the problem of missing data
Aim. To analyze the frequency of missing data on the time of pain onset, obtained from medical records and patient questionnaires for acute coronary syndrome (ACS), and to evaluate the factors associated with this missing data. Material and methods. The study was conducted as part of the prospective Stupino Registry of ACS (STOCS), which has included all consecutive patients with ACS or suspected ACS admitted to the regional vascular center since January 10, 2025. Data on the time of angina pain onset were obtained from information in medical records and patient questionnaires. Results. Data from 261 patients included in the registry for the first 6 months of 2025 were analyzed. Referral diagnoses and diagnoses established upon hospital admission did not comply with current clinical guidelines in almost a third of patients. An analysis of patient records revealed that data on the angina onset was available for only 212 patients and missing for 49 (18,8%). Analysis of questionnaires completed by patients revealed missing information on pain onset in 3,1% of cases. The following factors were associated with missing data in patient records: older age, ST-segment elevation, and prior cerebrovascular accident. Older age and inhospital death were also associated with missing information in patient records. Conclusion. The study results showed that missing data on the pain onset was present in almost one in five patient records and in only 3% of structured questionnaires completed by patients. The lack of information about the pain onset in medical records and patient questionnaires is not accidental and is associated with a number of factors (advanced age, prior cerebrovascular accident, and inhospital death). Missing data on pain onset can be partially filled in through a structured patient survey, but it is virtually impossible to completely eliminate these omissions.
- Open Access
- 14 January 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (5) , 457-465
Pharmacotherapy safety and treatment nonadherence: an ambiguous alliance (data from an outpatient registry)
Aim . To analyze data on adverse drug reactions (ADRs) from medical history and assess pharmacotherapy (PT) adherence among patients within an outpatient registry. This study aims to investigate the relationship between these variables and determine their potential priority. Material and methods . A cross-sectional study was conducted using data from the “PROFILE” outpatient registry, which included 2,619 patients with cardiovascular diseases (CVD) and associated risk factors from 2014 to 2024. Information on PT adherence and the history of ADRs was collected during physician consultations at the point of registry enrollment and recorded on individualized registration forms. ADR presence was assessed based on whether or not patients reported previous reactions. Patients were classified as adherent if they reported regular use of prescribed medications, partially adherent if they used medications irregularly, and nonadherent if they refused medication entirely. Patients not prescribed PT at the time of registry inclusion were excluded from adherence analysis. Results . A comparative analysis was conducted between subgroups of patients based on the ADRs presence or absence in their medical histories. At the initial visit, ADRs were reported in 492 (18.8%) patients. Of these, three patients indicated they had not been prescribed pharmacotherapy. Among the remaining 489 patients, 365 (74.6%) were classified as adherent, 31 (6.3%) were nonadherent, and 93 (19.1%) reported irregular adherence. Only 9 (7.3%) out of 124 nonadherent individuals in this subgroup cited ADRs as the reason for their nonadherence.Among 2,127 patients without ADRs in their medical histories, 36 indicated that PT had not been prescribed. Of the 2,091 remaining individuals, 1,397 (66.8%) were adherent, while adherence issues were identified in 33.2%: 428 (20.5%) refused medication, and 266 (12.7%) took medications irregularly. In this subgroup, only 7 (9.6%) patients attributed their nonadherence to concerns about ADRs. The primary reason for nonadherence in both subgroups was an unwillingness to follow long-term treatment regimens.Multivariate logistic regression analysis identified five independent variables out of ten that demonstrated statistically significant associations with ADR presence: female sex (OR=1.67; 95% CI: 1.30-2.14; pConclusion . The data from the outpatient registry revealed that nonadherence was more prevalent among patients without documented ADRs in their medical histories compared to those with ADRs (every third patient versus every fourth). ADRs were shown to be a direct cause of nonadherence in less than 10% of cases. Patients who exhibit nonadherence to pharmacotherapy are more likely to have ADRs in their medical histories. Consequently, it appears that adherence takes precedence in the relationship between safety and pharmacotherapy: any deviations from prescribed regimens may lead to increased risks associated with medication use.
- 14 January 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (5) , 457-465
Open AccessPharmacotherapy safety and treatment nonadherence: an ambiguous alliance (data from an outpatient registry)
Aim . To analyze data on adverse drug reactions (ADRs) from medical history and assess pharmacotherapy (PT) adherence among patients within an outpatient registry. This study aims to investigate the relationship between these variables and determine their potential priority. Material and methods . A cross-sectional study was conducted using data from the “PROFILE” outpatient registry, which included 2,619 patients with cardiovascular diseases (CVD) and associated risk factors from 2014 to 2024. Information on PT adherence and the history of ADRs was collected during physician consultations at the point of registry enrollment and recorded on individualized registration forms. ADR presence was assessed based on whether or not patients reported previous reactions. Patients were classified as adherent if they reported regular use of prescribed medications, partially adherent if they used medications irregularly, and nonadherent if they refused medication entirely. Patients not prescribed PT at the time of registry inclusion were excluded from adherence analysis. Results . A comparative analysis was conducted between subgroups of patients based on the ADRs presence or absence in their medical histories. At the initial visit, ADRs were reported in 492 (18.8%) patients. Of these, three patients indicated they had not been prescribed pharmacotherapy. Among the remaining 489 patients, 365 (74.6%) were classified as adherent, 31 (6.3%) were nonadherent, and 93 (19.1%) reported irregular adherence. Only 9 (7.3%) out of 124 nonadherent individuals in this subgroup cited ADRs as the reason for their nonadherence.Among 2,127 patients without ADRs in their medical histories, 36 indicated that PT had not been prescribed. Of the 2,091 remaining individuals, 1,397 (66.8%) were adherent, while adherence issues were identified in 33.2%: 428 (20.5%) refused medication, and 266 (12.7%) took medications irregularly. In this subgroup, only 7 (9.6%) patients attributed their nonadherence to concerns about ADRs. The primary reason for nonadherence in both subgroups was an unwillingness to follow long-term treatment regimens.Multivariate logistic regression analysis identified five independent variables out of ten that demonstrated statistically significant associations with ADR presence: female sex (OR=1.67; 95% CI: 1.30-2.14; pConclusion . The data from the outpatient registry revealed that nonadherence was more prevalent among patients without documented ADRs in their medical histories compared to those with ADRs (every third patient versus every fourth). ADRs were shown to be a direct cause of nonadherence in less than 10% of cases. Patients who exhibit nonadherence to pharmacotherapy are more likely to have ADRs in their medical histories. Consequently, it appears that adherence takes precedence in the relationship between safety and pharmacotherapy: any deviations from prescribed regimens may lead to increased risks associated with medication use.
- Open Access
- 11 November 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (9) , 4505
Prognostic value of atrial fibrillation at different stages of longterm outpatient followup in patients after cerebrovascular accident (based on the REGIONM registry)
Aim. To study the prognostic value of atrial fibrillation (AF) during longterm follow-up of patients with cerebrovascular accident (CVA). Material and methods. The study was conducted as part of the prospective part of the retrospective-prospective registry REGION-M registry. A total of 684 patients discharged from the hospital with a confirmed CVA between 2012 and 2017 and assigned to an outpatient clinic were included. The median follow-up was 5,0 [2,0; 6,8] years. AF was determined based on the diagnosis during the patient's hospital stay and/or at the first outpatient visit after discharge. The primary endpoint was all-cause death. An analysis of AF prognostic role was conducted for the entire follow-up period from hospital discharge to 2022. Results. Patients with AF accounted for 29,2% (n=200). Comparison of the groups of patients with and without AF showed that patients with AF were older and had a higher number of comorbidities. AF had a paradoxical positive effect on the death risk (hazard ratio (HR) 0,998 (95% confidence interval (CI): 0,996-1,000), p=0,017). In this regard, we suggested that the AF effect on cumulative survival was disproportionate, i.e. changed over time. Therefore, the contribution of AF to death risk was assessed separately for three follow-up periods as follows: early outpatient follow-up — from discharge to contact in 20172018; intermediate — from the moment of the previous follow-up (2017 or 2018) to May 2020; long-tern — from 2020 to 2022. Differences in death risk between patients with and without AF were significant only in early (HR 1,003 (95% CI: 1,000-1,005) (p=0,016)) and intermediate (HR 1,004 (95% CI: 1,001-1,007) periods (p=0,016)). No significant differences in death risk between patients with and without AF were observed in the long-term follow-up period. Therefore, AF was not included in the multivariate regression analysis. Conclusion. AF negatively impacts the death risk during the first 3-4 years after CVA. After this period, AF loses its independent prognostic significance.
- 11 November 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (9) , 4505
Open AccessPrognostic value of atrial fibrillation at different stages of longterm outpatient followup in patients after cerebrovascular accident (based on the REGIONM registry)
Aim. To study the prognostic value of atrial fibrillation (AF) during longterm follow-up of patients with cerebrovascular accident (CVA). Material and methods. The study was conducted as part of the prospective part of the retrospective-prospective registry REGION-M registry. A total of 684 patients discharged from the hospital with a confirmed CVA between 2012 and 2017 and assigned to an outpatient clinic were included. The median follow-up was 5,0 [2,0; 6,8] years. AF was determined based on the diagnosis during the patient's hospital stay and/or at the first outpatient visit after discharge. The primary endpoint was all-cause death. An analysis of AF prognostic role was conducted for the entire follow-up period from hospital discharge to 2022. Results. Patients with AF accounted for 29,2% (n=200). Comparison of the groups of patients with and without AF showed that patients with AF were older and had a higher number of comorbidities. AF had a paradoxical positive effect on the death risk (hazard ratio (HR) 0,998 (95% confidence interval (CI): 0,996-1,000), p=0,017). In this regard, we suggested that the AF effect on cumulative survival was disproportionate, i.e. changed over time. Therefore, the contribution of AF to death risk was assessed separately for three follow-up periods as follows: early outpatient follow-up — from discharge to contact in 20172018; intermediate — from the moment of the previous follow-up (2017 or 2018) to May 2020; long-tern — from 2020 to 2022. Differences in death risk between patients with and without AF were significant only in early (HR 1,003 (95% CI: 1,000-1,005) (p=0,016)) and intermediate (HR 1,004 (95% CI: 1,001-1,007) periods (p=0,016)). No significant differences in death risk between patients with and without AF were observed in the long-term follow-up period. Therefore, AF was not included in the multivariate regression analysis. Conclusion. AF negatively impacts the death risk during the first 3-4 years after CVA. After this period, AF loses its independent prognostic significance.
- Open Access
- 24 September 2025
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (3) , 571-577
ST-segment Elevation Myocardial Infarction. Study Data
Relevance. Kardiovascular diseases remain the leading cause of disability and mortality among people of all ages, not only in Russia, but also in other developed countries. Death from myocardial infarction occurs from its complications. The creation of vascular centers in the Russian Federation, as well as the use of modern technologies for the provision of specialized care for acute coronary syndrome (ACS) have clearly led to a decrease in cases of complicated myocardial infarction and mortality rates from them in general. At the same time, the still fairly frequent occurrence of these life-threatening conditions requires further efforts to improve the quality of their diagnosis and treatment.Aim of Study. To study the course of complicated myocardial infarction (MI) and assess the frequency of its early and late complications.Material and Methods. The study included 2,172 patients who were treated in the emergency cardiology department for patients with MI of the N.V. Sklifosovsky Research Institute for Emergency Medicine for the period from 2011 to 2021 with complicated MI. This cohort accounted for 79% of the total number of hospitalized patients (n=2,741) during the specified observation period. All patients underwent the necessary diagnostic methods and received treatment at a modern level.Results. The article presents information on the treatment outcomes of patients with complicated MI for the period from 2011 to 2021. The frequency of various MI complications was analyzed, taking into account the modern approach to providing specialized care to patients with ACS within the regional vascular center. As a result of the study, complications in acute myocardial infarction, their frequency of development were studied and algorithms for optimizing the modern approach to diagnosis, prevention and treatment of these complications were developed. The study noted a statistically significant decrease in the frequency of such complications by 1.5–15 times in most cases, especially early post-infarction angina, left ventricular aneurysm formation, mechanical myocardial damage (myocardial ruptures), as well as the development of Dressler syndrome.Conclusion. It has been established that as specialized care for patients with acute coronary syndrome with ST segment elevation improves within the framework of the network of vascular centers, a decrease in the number of complications at different stages of the disease and mortality in general is observed. However, complications such as cardiogenic shock and heart failure dictate the need for further study and development of modern methods for their prevention and treatment.
- 24 September 2025
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (3) , 571-577
Open AccessST-segment Elevation Myocardial Infarction. Study Data
Relevance. Kardiovascular diseases remain the leading cause of disability and mortality among people of all ages, not only in Russia, but also in other developed countries. Death from myocardial infarction occurs from its complications. The creation of vascular centers in the Russian Federation, as well as the use of modern technologies for the provision of specialized care for acute coronary syndrome (ACS) have clearly led to a decrease in cases of complicated myocardial infarction and mortality rates from them in general. At the same time, the still fairly frequent occurrence of these life-threatening conditions requires further efforts to improve the quality of their diagnosis and treatment.Aim of Study. To study the course of complicated myocardial infarction (MI) and assess the frequency of its early and late complications.Material and Methods. The study included 2,172 patients who were treated in the emergency cardiology department for patients with MI of the N.V. Sklifosovsky Research Institute for Emergency Medicine for the period from 2011 to 2021 with complicated MI. This cohort accounted for 79% of the total number of hospitalized patients (n=2,741) during the specified observation period. All patients underwent the necessary diagnostic methods and received treatment at a modern level.Results. The article presents information on the treatment outcomes of patients with complicated MI for the period from 2011 to 2021. The frequency of various MI complications was analyzed, taking into account the modern approach to providing specialized care to patients with ACS within the regional vascular center. As a result of the study, complications in acute myocardial infarction, their frequency of development were studied and algorithms for optimizing the modern approach to diagnosis, prevention and treatment of these complications were developed. The study noted a statistically significant decrease in the frequency of such complications by 1.5–15 times in most cases, especially early post-infarction angina, left ventricular aneurysm formation, mechanical myocardial damage (myocardial ruptures), as well as the development of Dressler syndrome.Conclusion. It has been established that as specialized care for patients with acute coronary syndrome with ST segment elevation improves within the framework of the network of vascular centers, a decrease in the number of complications at different stages of the disease and mortality in general is observed. However, complications such as cardiogenic shock and heart failure dictate the need for further study and development of modern methods for their prevention and treatment.
- Open Access
- 22 August 2025
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (3) , 226-233
Practice of percutaneous coronary interventions in non-ST-elevation acute coronary syndrome (based on the CONTRAST registry data)
Aim. To assess real-world practice in the use of invasive diagnostic and treatment methods in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) within the registry of the regional vascular centre.Material and methods. The study included 136 patients consecutively admitted on an emergency basis to the vascular center in Sergiyev Posad between October 2018 and March 2019 with a diagnosis of NSTE-ACS. The mean age was 63±11 years, and 61% were male.Results. All patients underwent coronary angiography (CAG) as soon as possible after hospital admission (less than 2 hours). None of the patients had absolute contraindications for percutaneous coronary intervention (PCI). All 136 patients were divided into 3 groups based on the chosen invasive treatment strategy: patients who did not undergo PCI at the inpatient stage of treatment and with long-term follow-up — 69 people (50.7%; group 1); patients who underwent PCI during the current hospitalisation — 50 people (36.8%; group 2); patients who underwent delayed PCI after the current hospitalisation — 17 people (12.5%; group 3). The decision to perform PCI was not influenced by the disease patterns or the GRACE risk score. The results of the CAG showed that patients in group 3 had three-vessel coronary artery disease significantly more often than in groups 1 and 2 (59% vs 22% and 34%, p=0.001). Regression analysis showed that the detection of damage to only one coronary artery significantly increased the likelihood of PCI. This probability progressively decreased as the extent of CAD increased.Conclusion. In the regional vascular centre, in-hospital PCI was performed in only 36% of patients diagnosed with NSTE-ACS. When deciding on PCI, physicians were primarily guided not by the degree of risk of cardiovascular complications, as required by clinical guidelines, but rather by the technical feasibility and safety of the procedure.
- 22 August 2025
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (3) , 226-233
Open AccessPractice of percutaneous coronary interventions in non-ST-elevation acute coronary syndrome (based on the CONTRAST registry data)
Aim. To assess real-world practice in the use of invasive diagnostic and treatment methods in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) within the registry of the regional vascular centre.Material and methods. The study included 136 patients consecutively admitted on an emergency basis to the vascular center in Sergiyev Posad between October 2018 and March 2019 with a diagnosis of NSTE-ACS. The mean age was 63±11 years, and 61% were male.Results. All patients underwent coronary angiography (CAG) as soon as possible after hospital admission (less than 2 hours). None of the patients had absolute contraindications for percutaneous coronary intervention (PCI). All 136 patients were divided into 3 groups based on the chosen invasive treatment strategy: patients who did not undergo PCI at the inpatient stage of treatment and with long-term follow-up — 69 people (50.7%; group 1); patients who underwent PCI during the current hospitalisation — 50 people (36.8%; group 2); patients who underwent delayed PCI after the current hospitalisation — 17 people (12.5%; group 3). The decision to perform PCI was not influenced by the disease patterns or the GRACE risk score. The results of the CAG showed that patients in group 3 had three-vessel coronary artery disease significantly more often than in groups 1 and 2 (59% vs 22% and 34%, p=0.001). Regression analysis showed that the detection of damage to only one coronary artery significantly increased the likelihood of PCI. This probability progressively decreased as the extent of CAD increased.Conclusion. In the regional vascular centre, in-hospital PCI was performed in only 36% of patients diagnosed with NSTE-ACS. When deciding on PCI, physicians were primarily guided not by the degree of risk of cardiovascular complications, as required by clinical guidelines, but rather by the technical feasibility and safety of the procedure.